With the efforts that were undertaken by Mumbai’s civic body, the Brihanmumbai Municipal Corporation (BMC), cases of Mucormycosis have been on a decline.
Mucormycosis happens to be a serious but rare fungal infection caused by a group of molds called mucormycetes. The infection targets COVID-19 patients with comorbidities like diabetes and is dangerous, even after one recovers from the coronavirus.
According to sources, out of 804 patients admitted for treatment in Mumbai hospitals, 436 patients have recovered. At present, 212 active patients are undergoing treatment in various hospitals. Moreover, private hospitals, including KEM, Nair, Sion and Cooper hospitals in the municipality, are reportedly treating cases of Mucormycosis.
On the other hand, over the last three months, Maharashtra has recorded a 9 per cent mortality rate in citizens with coronavirus associated mucormycosis or black fungus. As per reports, the death rate is much below the 30-50 per cent range that was seen in mucormycosis patients before the pandemic. From the total 7,359 CAM patients in Maharashtra till June, 14,653 have succumbed.
Moreover, of the five worst-hit districts of the state, Pune recorded a 12 per cent mortality rate, Nashik 10 per cent, Mumbai 9 per cent, Nagpur 8 per cent, and Aurangabad 7 per cent.
ALSO READ: Maharashtra: Black Fungus fatality rate recorded at 9%
Share
Tweet
